415 Capital
Overview
415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, our team has empowered exceptional entrepreneurs through …
Investment Focus
- Innovative medical device technologies addressing cardiovascular and neurovascular diseases
- Clinical-stage companies
- Companies based in Europe, Israel, or North America
Portfolio Companies
Reach 415 Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about 415 Capital
What sectors does 415 Capital invest in?
415 Capital invests in Healthcare, Digital Health, Medical Devices, Biotechnology and Medical Technology, and is based in München, Germany. 415 Capital is listed as a vc in the ConnectSafely investor database.
What stage does 415 Capital invest at?
415 Capital backs companies at Early Stage and Growth, writing cheques of 5M - 15M.
Which regions does 415 Capital invest in?
415 Capital invests across United States, Germany and Israel.
Who are the partners at 415 Capital?
Team members listed for 415 Capital include Rob Michiels (Senior Venture Partner) and Michael Braun (Senior Venture Partner).
What companies has 415 Capital invested in?
415 Capital's portfolio includes Distalmotion, Supira Medical, R3 Vascular, CorFlow Therapeutics and TRiCares.
How do I contact 415 Capital?
415 Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
